Tarsa Therapeutics' Series B Round

Tarsa Therapeutics raised a round of funding on March 18, 2012.

Tarsa Therapeutics develops therapies for the treatment and prevention of osteoporosis and related bone diseases. The company is developing OSTORA, an oral formulation of calcitonin for the treatment …

Articles about Tarsa Therapeutics' Series B Round: